How do you make component quality predictable?
As biologics and combination products become increasingly demanding, variability at the component level can introduce risks across development and manufacturing.
In this video, Estelle Verger and Nicolas Voisin from Aptar Pharma’s Injectables business explore what it takes to achieve predictable component quality and what pharma and biotech teams should expect from their component partners.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
